Zdrowie i gospodarka · 24/07/1998
FDA Releases Draft Guidance on Reporting Impurities in Drug Substances for ANDA's
The Food and Drug Administration (FDA) has released a draft guidance document outlining recommendations for pharmaceutical companies on how to report impurities in drug substances used in abbreviated new drug applications (ANDA's).